260 related articles for article (PubMed ID: 35953726)
21. Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine.
Udler MS; McCarthy MI; Florez JC; Mahajan A
Endocr Rev; 2019 Dec; 40(6):1500-1520. PubMed ID: 31322649
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic Subtypes of OSA: A Challenge and Opportunity for Precision Medicine.
Zinchuk A; Yaggi HK
Chest; 2020 Feb; 157(2):403-420. PubMed ID: 31539538
[TBL] [Abstract][Full Text] [Related]
23. Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes.
Marucci A; Rutigliano I; Fini G; Pezzilli S; Menzaghi C; Di Paola R; Trischitta V
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052457
[TBL] [Abstract][Full Text] [Related]
24. Precision Medicine in Patients with Differential Diabetic Phenotypes: Novel Opportunities from Network Medicine.
Napoli C; Benincasa G; Ellahham S
Curr Diabetes Rev; 2022; 18(8):e221221199301. PubMed ID: 34951369
[TBL] [Abstract][Full Text] [Related]
25. A roadmap to achieve pharmacological precision medicine in diabetes.
Florez JC; Pearson ER
Diabetologia; 2022 Nov; 65(11):1830-1838. PubMed ID: 35748917
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing for maturity-onset diabetes of the young resulting in an upgraded genetic classification of an HNF1A gene variant: a case report.
Pollack-Schreiber N; Nwosu BU; Salemi P
Front Endocrinol (Lausanne); 2023; 14():1173471. PubMed ID: 37396173
[TBL] [Abstract][Full Text] [Related]
27. Novel insights into genetics and clinics of the HNF1A-MODY.
Valkovicova T; Skopkova M; Stanik J; Gasperikova D
Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
[TBL] [Abstract][Full Text] [Related]
28. The Need for Precision Medicine to be Applied to Diabetes.
Klonoff DC; Florez JC; German M; Fleming A
J Diabetes Sci Technol; 2020 Nov; 14(6):1122-1128. PubMed ID: 31903769
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Skyler JS; Bakris GL; Bonifacio E; Darsow T; Eckel RH; Groop L; Groop PH; Handelsman Y; Insel RA; Mathieu C; McElvaine AT; Palmer JP; Pugliese A; Schatz DA; Sosenko JM; Wilding JP; Ratner RE
Diabetes; 2017 Feb; 66(2):241-255. PubMed ID: 27980006
[TBL] [Abstract][Full Text] [Related]
30. Network medicine and type 2 diabetes mellitus: insights into disease mechanism and guide to precision medicine.
Loscalzo J
Endocrine; 2019 Dec; 66(3):456-459. PubMed ID: 31410748
[TBL] [Abstract][Full Text] [Related]
31. Defining Heterogeneity Among Women With Gestational Diabetes Mellitus.
Powe CE; Hivert MF; Udler MS
Diabetes; 2020 Oct; 69(10):2064-2074. PubMed ID: 32843565
[TBL] [Abstract][Full Text] [Related]
32. Innovations in personalised diabetes care and risk management.
Nijpels G; Beulens JW; van der Heijden AA; Elders PJ
Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):125-132. PubMed ID: 31766922
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications.
Naylor RN; John PM; Winn AN; Carmody D; Greeley SA; Philipson LH; Bell GI; Huang ES
Diabetes Care; 2014; 37(1):202-9. PubMed ID: 24026547
[TBL] [Abstract][Full Text] [Related]
34. Maturity-onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus.
Horikawa Y
J Diabetes Investig; 2018 Jul; 9(4):704-712. PubMed ID: 29406598
[TBL] [Abstract][Full Text] [Related]
35. Utility of genetic risk scores in type 1 diabetes.
Luckett AM; Weedon MN; Hawkes G; Leslie RD; Oram RA; Grant SFA
Diabetologia; 2023 Sep; 66(9):1589-1600. PubMed ID: 37439792
[TBL] [Abstract][Full Text] [Related]
36. [Molecular genetics of maturity-onset diabetes of the young].
Voevoda MI; Ivanova AA; Shakhtshneider EV; Ovsyannikova AK; Mikhailova SV; Astrakova KS; Voevoda SM; Rymar OD
Ter Arkh; 2016; 88(4):117-124. PubMed ID: 28635922
[TBL] [Abstract][Full Text] [Related]
37. Identifying obesity subtypes: A review of studies utilising clinical biomarkers and genetic data.
Abraham A; Yaghootkar H
Diabet Med; 2023 Dec; 40(12):e15226. PubMed ID: 37704218
[TBL] [Abstract][Full Text] [Related]
38. From Individualized to Personalized Medicine in Diabetes: An Expert Overview.
Mohan V; Das AK; Mukherjee JJ; Seshadri K; Jha S; Kalra S
J Assoc Physicians India; 2019 Sep; 67(9):78-82. PubMed ID: 31561694
[TBL] [Abstract][Full Text] [Related]
39. Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation.
Althari S; Najmi LA; Bennett AJ; Aukrust I; Rundle JK; Colclough K; Molnes J; Kaci A; Nawaz S; van der Lugt T; Hassanali N; Mahajan A; Molven A; Ellard S; McCarthy MI; Bjørkhaug L; Njølstad PR; Gloyn AL
Am J Hum Genet; 2020 Oct; 107(4):670-682. PubMed ID: 32910913
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of MODY - brief overview for clinical practice].
Urbanová J; Brunerová L; Brož J
Vnitr Lek; 2018; 64(4):367-374. PubMed ID: 29791171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
